These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 198597)

  • 21. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit.
    Hayashi K; Masuda K
    Jpn J Ophthalmol; 1982; 26(4):437-42. PubMed ID: 6187959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N; Yosida T; Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract]   [Full Text] [Related]  

  • 23. Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat.
    Racusen LC; Binder HJ
    Gastroenterology; 1977 Oct; 73(4 Pt 1):790-6. PubMed ID: 19342
    [No Abstract]   [Full Text] [Related]  

  • 24. VIP-induced cyclic AMP formation in the cat submandibular gland. Potentiation by carbacholine.
    Fredholm BB; Lundberg JM
    Acta Physiol Scand; 1982 Jan; 114(1):157-9. PubMed ID: 6291326
    [No Abstract]   [Full Text] [Related]  

  • 25. Vasoactive intestinal polypeptide (VIP) in lung function and disease.
    Said SI
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1525-31. PubMed ID: 1687288
    [No Abstract]   [Full Text] [Related]  

  • 26. Relaxant effects of atrial natriuretic polypeptide on guinea pig tracheal smooth muscle.
    Watanabe H; Takagi K; Satake T
    Prog Biochem Pharmacol; 1988; 23():136-41. PubMed ID: 2847186
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3',5'-monophosphate-dependent mechanism.
    Hohmann EL; Levine L; Tashjian AH
    Endocrinology; 1983 Apr; 112(4):1233-9. PubMed ID: 6187560
    [No Abstract]   [Full Text] [Related]  

  • 28. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of papaverine and vasointestinal polypeptide on penile and vascular cAMP and cGMP in control and diabetic animals: an in vitro study.
    Miller MA; Morgan RJ; Thompson CS; Mikhailidis DP; Jeremy JY
    Int J Impot Res; 1995 Jun; 7(2):91-100. PubMed ID: 7496446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cyclic AMP-dependent protein kinases by vasoactive intestinal peptide (VIP) in isolated intestinal epithelial cells from rat.
    Laburthe M; Mangeat P; Marchis-Mouren G; Rosselin G
    Life Sci; 1979 Nov; 25(22):1931-7. PubMed ID: 231169
    [No Abstract]   [Full Text] [Related]  

  • 31. Antagonistic effect of a vasoactive intestinal peptide fragment, vasoactive intestinal peptide(1-11), on guinea pig trachea smooth muscle relaxation.
    Goossens JF; Pommery N; Lohez M; Pommery J; Helbecque N; Cotelle P; Lhermitte M; Henichart JP
    Mol Pharmacol; 1992 Jan; 41(1):104-9. PubMed ID: 1732717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture.
    Rousset M; Laburthe M; Chevalier G; Boissard C; Rosselin G; Zweibaum A
    FEBS Lett; 1981 Apr; 126(1):38-40. PubMed ID: 6263686
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on hemodynamics and functions of the pancreas. I. Effect of VIP on normal pancreas (author's transl)].
    Inoue K; Kawano T; Shima K; Kim T; Suzuki T; Tobe T; Yajima H
    Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1413-23. PubMed ID: 7441916
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation by vasoactive intestinal peptide of cyclic AMP accumulation in gastric epithelial glands. A characteristic of human stomach.
    Dupont C; Gespach C; Chenut B; Rosselin G
    FEBS Lett; 1980 Apr; 113(1):25-8. PubMed ID: 6247200
    [No Abstract]   [Full Text] [Related]  

  • 35. [The lung as a metabolic organ].
    Kitamura S
    Masui; 1976 Oct; 25(20):925-33. PubMed ID: 186647
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung.
    Undem BJ; Dick EC; Buckner CK
    Eur J Pharmacol; 1983 Mar; 88(2-3):247-50. PubMed ID: 6189733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VIP-and glucagon-induced formation of cyclic AMP in intact retinae in vitro.
    Schorderet M; Sovilla JY; Magistretti PJ
    Eur J Pharmacol; 1981 Apr; 71(1):131-3. PubMed ID: 6263646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of cyclic AMP accumulation in a rat sympathetic ganglion: effects of vasoactive intestinal polypeptide.
    Volle RL; Patterson BA
    J Neurochem; 1982 Oct; 39(4):1195-7. PubMed ID: 6288862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of chlorpromazine, beta-endorphin and vasoactive intestinal polypeptide on plasma growth hormone levels in unanesthetized rats (author's transl)].
    Wakabayashi I; Miyoshi H; Oomura E; Shizume K
    Horumon To Rinsho; 1980; 28(6):633-8. PubMed ID: 7418239
    [No Abstract]   [Full Text] [Related]  

  • 40. [Plasma and urinary cyclic nucleotides in parathyroid disorders--effect of parathyroid hormone (author's transl)].
    Nakagawa H; Tomita A; Mitsuma T; Uchikawa T; Konagaya Y; Imagawa T
    Nihon Naika Gakkai Zasshi; 1978 Nov; 67(11):1406-11. PubMed ID: 215680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.